| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.12B | +6.7% |
| Cost of Revenue | $583.5M | +12.0% |
| Gross Profit | $538.7M | +1.5% |
| R&D Expense | $27.2M | +5.5% |
| SG&A Expense | $246.9M | -5.4% |
| Operating Income | $233.3M | +11.7% |
| Interest Expense | $50.3M | -25.1% |
| Pre-tax Income | $184.6M | +28.1% |
| Income Tax | $33.1M |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $329.6M | +67.7% |
| Short-term Investments | $69.5M | — |
| Accounts Receivable | $280.2M | +0.6% |
| Inventory | $210.7M | -2.6% |
| Current Assets | $951.2M | +24.0% |
| Total Assets | $3.15B | +5.4% |
| Current Liabilities | $323.2M | +3.3% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $256.0M | +20.7% |
| Capital Expenditures | $28.7M | +18.2% |
| Investing Cash Flow | -$103.8M | -91.7% |
| Financing Cash Flow | -$20.8M | +84.8% |
| Free Cash Flow | $227.3M | +21.1% |
| +29.5% |
| Net Income | $151.6M | +27.7% |
| EPS (Basic) | $0.70 | +27.3% |
| EPS (Diluted) | $0.68 | +25.9% |
| Long-term Debt |
| $959.8M |
| -1.2% |
| Total Liabilities | $1.56B | -0.6% |
| Stockholders' Equity | $1.59B | +11.9% |